Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2396-2403

  Gu, Junxia ^a   Liang, Yuting ^a   Qiao, Longwei ^a   Li, Xiaoyun ^a   Li, Xingang ^b   Lu, Yaojuan ^a   Zheng, Qiping ^a,c  

^a JIANGSU UNIVERSITY   (China)

^b Anyang Cancer Hospital   (China)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endometrioid adenocarcinoma; Immunohistochemistry; Tissue microarray; URI RMP

Indexed keywords

SIGNAL PEPTIDE; TUMOR MARKER; URI1 PROTEIN, HUMAN;

ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CHEMISTRY; ENDOMETRIOID ADENOCARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; TISSUE MICROARRAY; UPREGULATION; URI/RMP;

ENDOMETRIOID ADENOCARCINOMA; IMMUNOHISTOCHEMISTRY; TISSUE MICROARRAY; URI/RMP;

CARCINOMA, ENDOMETRIOID; CELL DIFFERENTIATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84887089486     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Dorjsuren D, Lin Y, Wei W, Yamashita T, Nomura T, Hayashi N, Murakami S. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol 1998;18:7546-55.
2. Gstaiger M, Luke B, Hess D, Oakeley EJ, Wirbelauer C, Blondel M, Vigneron M, Peter M, Krek W. Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science 2003;302:1208-12.
3. Wei W, Gu JX, Zhu CQ, Sun FY, Dorjsuren D, Lin Y, Murakami S. Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP). Cell Res 2003;13:111-20.
4. Yang S, Wang H, Guo Y, Chen S, Zhang MY, Shen J, Yu H, Miao J, Wang HY, Wei W. RMP Plays Distinct Roles in the Proliferation of Hepatocellular Carcinoma Cells and Normal Hepatic Cells. Int J Biol Sci 2013;9:637-48.
5. Yang H, Gu J, Zheng Q, Li M, Lian X, Miao J, Jiang J, Wei W. RPB5-mediating protein is required for the proliferation of hepatocellular carcinoma cells. J Biol Chem 2011;286:11865-74.
6. Theurillat JP, Metzler SC, Henzi N, Djouder N, Helbling M, Zimmermann AK, Jacob F, Soltermann A, Caduff R, Heinzelmann-Schwarz V, Moch H, Krek W. URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell 2011;19:317-32.
7. Mita P, Savas JN, Djouder N, Yates JR 3rd, Ha S, Ruoff R, Schafler ED, Nwachukwu JC, Tanese N, Cowan NJ, Zavadil J, Garabedian MJ, Logan SK. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP. Mol Cell Biol 2011;31:3639-52.
8. Gu J, Li X, Liang Y, Qiao L, Ran D, Lu Y, Li X, Wei W, Zheng Q. Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis. Int J Clin Exp Pathol 2013;6:669-77.
9. Oldenburg CS, Boll D, Nicolaije KA, Vos MC, Pijnenborg JM, Coebergh JW, Beijer S, van de Poll-Franse LV, Ezendam NP. The relationship of body mass index with quality of life among endometrial cancer survivors:a study from the population-based PROFILES registry. Gynecol Oncol 2013;129:216-21.
10. Nicolaije KA, Ezendam NP, Vos MC, Boll D, Pijnenborg JM, Kruitwagen RF, Lybeert ML, van de Poll-Franse LV. Follow-up practice in endometrial cancer and the association with patient and hospital characteristics:a study from the population-based PROFILES registry. Gynecol Oncol 2013;129:324-31.
11. Djouder N, Metzler SC, Schmidt A, Wirbelauer C, Gstaiger M, Aebersold R, Hess D, Krek W. S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling. Mol Cell 2007;28:28-40.
12. Deplazes A, Mockli N, Luke B, Auerbach D, Peter M. Yeast Uri1p promotes translation initiation and may provide a link to cotranslational quality control. EMBO J 2009;28:1429-41.
13. Kirchner J, Vissi E, Gross S, Szoor B, Rudenko A, Alphey L, White-Cooper H. Drosophila Uri, a PP1alpha binding protein, is essential for viability, maintenance of DNA integrity and normal transcriptional activity. BMC Mol Biol 2008;9:36.
14. Parusel CT, Kritikou EA, Hengartner MO, Krek W, Gotta M. URI-1 is required for DNA stability in C. elegans. Development 2006;133:621-9.
15. Tinelli A, Vergara D, Martignago R, Leo G, Malvasi A, Tinelli R. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer:a clinical review. Acta Obstet Gynecol Scand 2008;87:1101-13.
16. Bilgin T, Ozuysal S, Ozan H. A comparison of three histological grading systems in endometrial cancer. Arch Gynecol Obstet 2005;272:23-5.
17. Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Massuger LF. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Gynecol Oncol 2013;129:285-91.
18. Huvila J, Talve L, Carpén O, Edqvist PH, Pontén F, Grénman S, Auranen A. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma. Gynecol Oncol 2013;130:174-80.
19. Uharcek P. Prognostic factors in endometrial carcinoma. Obstet Gynaecol Res 2008;34:776-83.
20. Chaudhry P, Asselin E. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer 2009;16:363-80.
21. Bradford LS, Rauh-Hain JA, Schorge J, Birrer MJ, Dizon DS. Advances in the Management of Recurrent Endometrial Cancer. Am J Clin Oncol 2013 Jun 11;[Epub ahead of print].